Nov 08, 2023 / 09:30PM GMT
Operator
Hello. Thank you for standing by, and welcome to Xenon Pharmaceuticals Inc. Third Quarter 2023 Earnings Conference Call.
I would now like to turn the call over to Sherry Aulin, our CFO. You may now begin the conference.
Sherry Aulin - Xenon Pharmaceuticals Inc. - CFO
Thank you. Good afternoon, everyone. Thank you for joining us on our call and webcast to discuss Xenon's third quarter 2023 financial and operating results. Joining me are Ian Mortimer, Xenon's President and Chief Executive Officer; Dr. Chris Kenney, Xenon's Chief Medical Officer; and Dr. Chris Von Seggern, Xenon's Chief Commercial Officer. Ian will open today's call with a summary of our progress. Chris Kenney will provide an overview of our ongoing XEN1101 clinical programs, and Chris Von Seggern will summarize key findings from our market research around the potential of 1101 in the major -- in major depressive disorder or MDD treatment landscape. I will summarize our financial results, progress within our partnered programs and anticipated company milestone events before opening the
Q3 2023 Xenon Pharmaceuticals Inc Earnings Call Transcript
Nov 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers